Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis [EARLY_Phase 1]

View source ↗

Summary

The document notes that the clinical study of A-319 for active rheumatoid arthritis is in early Phase 1 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • A-319

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Rheumatoid Arthritis (RA) | EARLY_Phase 1 | Status: RECRUITING